The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction
S. Zhang, R. Cui Department of Cardiology, Heilongjiang Provincial Hospital, Harbin, Heilongjiang, P.R. China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction, by S. Zhang, R. Cui, published in Eur Rev Med Pharmacol Sci 2018; 22 (2): 523-531–DOI: 10.26355/eurrev_201801_14205–PMID: 29424913” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/14205
Free PDF Download![Creative Commons License](https://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
S. Zhang, R. Cui
The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 18
Pages: 9235-9235
DOI: 10.26355/eurrev_202009_22989